The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
Conditions: Aging Interventions: Other: vaccine Sponsors: State University of New York at Buffalo; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
Conditions: Meningitis, Meningococcal Interventions: Biological: rMenB+OMV NZ Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine
Conditions: Pneumococcal Vaccines Interventions: Biological: IVT PCV-25 Formulation A; Biological: IVT PCV-25 Formulation B; Biological: IVT PCV-25 Formulation C; Biological: PCV 20 Sponsors: Inventprise Inc.; Canadian Center for Vaccinology; Vaccine Evaluation Center, Canada; PATH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
ACTIVATE in Public Housing
Conditions: Pneumonia; Influenza; Varicella Zoster; Meningitis; COVID-19; Vaccine Hesitancy Interventions: Behavioral: Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination Sponsors: Charles Drew University of Medicine and Science Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp); Biological: 23-Valent Pneumococcal Polysaccharide Vaccine（PPV23）; Biological: Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) Sponsor: CanSino Biologics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp); Biological: 23-Valent Pneumococcal Polysaccharide Vaccine （PPV23）; Biological: Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) Sponsors: CanSino Biologics Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
Condition: Lymphoma Intervention: Biological: PCV20 Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
Condition: Lymphoma Intervention: Biological: PCV20 Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
Condition: Lymphoma Intervention: Biological: PCV20 Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy
Condition: Lymphoma Intervention: Biological: PCV20 Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
Condition: Pneumococcal Disease Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine; Biological: control pneumococcal polysaccharide vaccine Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
